Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THAP domain-containing protein 6 (THAP6) is a member of the THAP protein family characterized by the presence of a conserved THAP domain at the N-terminus. The THAP domain is a C2CH-type zinc-coordinating DNA-binding domain that belongs to the zinc finger superfamily[1][2][3]. These domains allow THAP proteins to function as sequence-specific DNA-binding factors and to regulate gene transcription. While the specific functional details of THAP6 are not well defined, THAP proteins in general are involved in transcriptional repression or activation, cell cycle regulation, apoptosis, and possibly in chromosome segregation and chromatin modification[1][2][3]. THAP proteins are present only in animals and have not been found in plants, yeast, or bacteria[3]. As of now, THAP6 itself is not recognized as a therapeutic target, nor are there known drugs, biomarkers, or clinical safety issues associated with it.
Not applicable; no known drugs targeting THAP6.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THAP domain-containing protein 6 (THAP6).